Mariner
HAE icon

Mariner’s Haemonetics HAE Stock Holding History

Mariner’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.08M Sell
14,455
-396
-3% -$25.4K ﹤0.01% 1883
2026
Q1 		$836K Buy
14,851
+3,760
+34% +$245K ﹤0.01% 2099
2025
Q4 		$890K Buy
+11,091
New +$745K ﹤0.01% 2026
2024
Q3 		– Sell
-2,727
Closed -$226K – 3334
2024
Q2 		$226K Buy
2,727
+315
+13% +$27.7K ﹤0.01% 2679
2024
Q1 		$206K Buy
+2,412
New +$189K ﹤0.01% 2748
2023
Q4 		– Sell
-2,357
Closed -$211K – 3107
2023
Q3 		$211K Buy
+2,357
New +$210K ﹤0.01% 2459

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mariner's HAE Position: Q2 2026 in Review

Mariner reduced its Haemonetics (HAE) stake by 2.7% in Q2 2026, selling an estimated $25.4K and leaving 14,455 shares worth $1.08M. The position accounts for ﹤0.01% of the portfolio, ranked #1883.

Mariner first reported a position in HAE in Q3 2023 and has held it in 6 quarters since. 330 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Mariner held 14,455 shares of Haemonetics worth $1.08M as of Q2 2026.
  • Mariner sold 396 Haemonetics shares in Q2 2026, an estimated $25.4K.
  • Haemonetics made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #1883 holding.
  • Mariner first reported a position in Haemonetics in Q3 2023 and has held it in 6 quarters since.
  • 330 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.